Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer.
Inoue Y, Fujishima M, Ono M, Masuda J, Ozaki Y, Maeda T, Uehiro N, Takahashi Y, Kobayashi T, Sakai T, Osako T, Ueno T, Ohno S.
Inoue Y, et al. Among authors: fujishima m.
Breast Cancer Res Treat. 2022 Nov;196(2):341-348. doi: 10.1007/s10549-022-06726-w. Epub 2022 Sep 24.
Breast Cancer Res Treat. 2022.
PMID: 36153381
Free PMC article.
Review.